Llwytho...
Alpha7 nicotinic receptors as therapeutic targets for Parkinson’s disease
Accumulating evidence suggests that CNS α7 nicotinic acetylcholine receptors (nAChRs) are important targets for the development of therapeutic approaches for Parkinson’s disease. This progressive neurodegenerative disorder is characterized by debilitating motor deficits, as well as autonomic problem...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Biochem Pharmacol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4600450/ https://ncbi.nlm.nih.gov/pubmed/26093062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2015.06.014 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|